LEP and metabolic syndrome: Consistent with this explanation, we confirmed the markers related to dyslipidemia (e.g., PPARγ and leptin) in oleic and palmitic acid (OAPA) and lipopolysaccharide (LPS) treated-HUVECs for mimicking atherosclerosis of artery as well as ABCA1 and its target miRNAs.